Receiving the recombinant shingles vaccine is associated with a lower risk of developing dementia among older adults who have ...

The potential reason why is fascinating.

Shingles, a condition triggered by the reactivation of the varicella-zoster virus in the body, can cause a “war zone” of inflammation in the brain.

At first glance, it doesn’t seem the most likely connection – between a vaccine to guard against the viral infection shingles and a game-changing advance in the prevention of dementia. But since the ...

The shingles vaccine can significantly reduce the chance of developing vascular dementia, while also lowering the risk of blood clots, heart attacks and death in people ages 50 and older, according to ...

Dec 5 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

(Mufid Majnun/Unsplash) As we get older, we face an increased risk of both dementia and shingles – but what if a single vaccine could provide protection against them both? There's already convincing ...

The same vaccine that keeps you safe from shingles could also do wonders for your brain, research out this week suggests. Scientists at Stanford University and others examined what happened after ...

Among older adults who received at least one dose of the recombinant shingles vaccine, vaccine effectiveness against any herpes zoster-related outcome was 56.1%. Getting a second dose yielded a ...